ルシフェラーゼアッセイ市場：測定法別、用途別-2025-2030年世界予測

ルシフェラーゼアッセイ市場は、2023年に15億米ドルと評価され、2024年には16億米ドルに達すると予測され、CAGR 7.03%で成長し、2030年には24億2,000万米ドルになると予測されています。

ルシフェラーゼアッセイは、特定の酵素の存在または活性を測定するために使用される生化学的分析であり、遺伝子発現研究から細胞生存率評価まで幅広い用途があります。これらのアッセイは、ルシフェラーゼ酵素の発光能力を利用したもので、世界中の研究室で不可欠なツールとなっています。その必要性は、特に創薬や薬剤開発において、化合物や経路の迅速なスクリーニングを可能にする、生物学的プロセスの高感度リアルタイムモニタリングの需要から生じています。応用範囲は広く、製薬、バイオテクノロジー、学術、臨床研究セクターを網羅しています。最終用途はヘルスケア機関、研究所、診断センターにまで及ぶ。

ルシフェラーゼアッセイ市場は、研究開発投資の増加、バイオテクノロジーの革新、高度な診断ツールを必要とする慢性疾患の蔓延の増加など、いくつかの主要成長要因の影響を受けています。シグナル強度や安定性を向上させる新しい変異型ルシフェラーゼの開発など最近の動向は、市場プレーヤーが製品ラインアップを拡充する大きなチャンスとなっています。アナリストらは、研究機関との協力関係を活用し、アッセイ感度とリアルタイムデータ解析を強化する技術に投資することを推奨しています。

しかし、市場成長は、アッセイキットや装置の高コスト、結果を歪めるバックグラウンド発光干渉に関わる潜在的な技術的限界といった課題に直面しています。費用対効果の高い生産技術やアッセイデザインの改良に関する調査を通じて、これらの限界に対処することが不可欠です。さらに、高度なアッセイアプリケーションに関するエンドユーザー向けの継続的な教育やトレーニングプログラムは、市場への浸透を促進することができます。

ビジネスの成長が見込まれる革新的な分野としては、複数の生物学的パラメータを同時に評価できるマルチプレックスルシフェラーゼアッセイの開発や、解釈のスピードと精度を高めるためのAI主導型分析プラットフォームとの統合などが挙げられます。最後に、同市場は技術進歩のペースが速いことが特徴であり、競争優位性を維持し、個別化医療やハイスループットスクリーニングにおける新たなニーズに対応するためには、研究開発への継続的な投資が必要です。

市場力学：急速に進化するルシフェラーゼアッセイ市場の主要市場インサイトを公開

ルシフェラーゼアッセイ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 分子生物学および遺伝子工学における応用の拡大
  • 遺伝子発現をリアルタイムで定量的に可視化する技術開発
  • 研究投資の拡大と政府支援
• 市場抑制要因
  • 発光を生成するための分子状酸素の必要性
• 市場機会
  • 飲料業界における微生物汚染チェックのための用途拡大
  • プレーヤー間の戦略的提携
• 市場の課題
  • 付随する技術的問題

ポーターのファイブフォースルシフェラーゼアッセイ市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、ルシフェラーゼアッセイ市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ルシフェラーゼアッセイ市場における外部からの影響の把握

外部マクロ環境要因は、ルシフェラーゼアッセイ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ルシフェラーゼアッセイ市場における競合情勢の把握

ルシフェラーゼアッセイ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスルシフェラーゼアッセイ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ルシフェラーゼアッセイ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ルシフェラーゼアッセイ市場における成功への道筋を描く

ルシフェラーゼアッセイ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 分子生物学と遺伝子工学への応用の拡大
    • 遺伝子発現をリアルタイムで定量的に可視化する技術開発
    • 調査への投資と政府の支援の増加
  • 抑制要因
    • 分子状酸素が発光を生み出す必要性
  • 機会
    • 飲料業界で微生物汚染のチェックに利用が増加
    • プレイヤー間の戦略的コラボレーション
  • 課題
    • 関連する技術的問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ルシフェラーゼアッセイ市場：方法別

• デュアルレポーターアッセイ
• フラッシュアッセイ
• グローアッセイ
• シングルレポーターアッセイ

第7章 ルシフェラーゼアッセイ市場：用途別

• 遺伝子発現
• 代謝活動
• タンパク質間相互作用
• 翻訳後修飾

第8章 南北アメリカのルシフェラーゼアッセイ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のルシフェラーゼアッセイ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのルシフェラーゼアッセイ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AAT Bioquest, Inc.
• Abcam PLC
• Active Motif, Inc.
• Biotium
• GeneCopoeia, Inc.
• Gold Biotechnology
• Invivogen
• Lonza Group AG
• Merck KGaA
• Molecular Devices, LLC
• Novus Biologicals
• OriGene Technologies, Inc.
• OZ Biosciences
• Perkin Elmer, Inc.
• Promega Corporation
• PromoCell GmbH
• SwitchGear Genomics, Inc.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. LUCIFERASE ASSAYS MARKET RESEARCH PROCESS
• FIGURE 2. LUCIFERASE ASSAYS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LUCIFERASE ASSAYS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LUCIFERASE ASSAYS MARKET DYNAMICS
• TABLE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DUAL REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY FLASH ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY GLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SINGLE REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY GENE EХPRESSION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METABOLIC ACTIVITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY POST-TRANSLATIONAL MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 25. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 37. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 39. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 74. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 82. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 84. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 104. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

The Luciferase Assays Market was valued at USD 1.50 billion in 2023, expected to reach USD 1.60 billion in 2024, and is projected to grow at a CAGR of 7.03%, to USD 2.42 billion by 2030.

Luciferase assays are biochemical analyses used to measure the presence or activity of specific enzymes, with applications ranging from gene expression studies to cell viability assessments. These assays capitalize on the luciferase enzyme's capability to produce luminescence, making them an indispensable tool in research laboratories globally. Their necessity arises from the demand for sensitive, real-time monitoring of biological processes, especially in drug discovery and development, where they facilitate rapid screening of compounds and pathways. The application scope is broad, encompassing pharmaceutical, biotech, academic, and clinical research sectors. End-use extends to healthcare institutions, research labs, and diagnostic centers.

The market for luciferase assays is influenced by several key growth factors including the rise in R&D investments, innovations in biotechnology, and the increasing prevalence of chronic diseases necessitating advanced diagnostic tools. Recent advancements, such as the development of new mutant luciferases that enhance signal strength and stability, present significant opportunities for market players to expand their product offerings. Analysts recommend capitalizing on collaborations with research institutions and investing in technology to enhance assay sensitivity and real-time data analytics.

However, market growth faces challenges such as high costs of assay kits and equipment, and potential technical limitations involving background luminescence interference which can skew results. Addressing these limitations through research into cost-effective production techniques and improved assay designs is essential. Furthermore, continuous education and training programs for end-users on advanced assay applications can drive market penetration.

Innovative areas poised for business growth include the development of multiplexed luciferase assays that can simultaneously assess multiple biological parameters, and integration with AI-driven analytics platforms to enhance interpretation speed and accuracy. Lastly, the market is characterized by fast-paced technological advances, necessitating ongoing investment in R&D to maintain competitive advantage and address emerging needs in personalized medicine and high-throughput screening.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Luciferase Assays Market

The Luciferase Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increased application in molecular biology and genetic engineering
  • Technological development to permit the quantitative visualization of gene expression in real time
  • Growing investment in research and government support
• Market Restraints
  • Necessity for molecular oxygen to generate luminescence
• Market Opportunities
  • Growing uses in beverage industry to check microbial contamination
  • Strategic collaboration between players
• Market Challenges
  • Associated technical issues

Porter's Five Forces: A Strategic Tool for Navigating the Luciferase Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Luciferase Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Luciferase Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Luciferase Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Luciferase Assays Market

A detailed market share analysis in the Luciferase Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Luciferase Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Luciferase Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Luciferase Assays Market

A strategic analysis of the Luciferase Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Luciferase Assays Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Active Motif, Inc., Biotium, GeneCopoeia, Inc., Gold Biotechnology, Invivogen, Lonza Group AG, Merck KGaA, Molecular Devices, LLC, Novus Biologicals, OriGene Technologies, Inc., OZ Biosciences, Perkin Elmer, Inc., Promega Corporation, PromoCell GmbH, SwitchGear Genomics, Inc., Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Luciferase Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Method, market is studied across Dual Reporter Assay, Flash Assay, Glow Assay, and Single Reporter Assay.
• Based on Application, market is studied across Gene Expression, Metabolic Activity, Protein-Protein Interaction, and Post-Translational Modification.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increased application in molecular biology and genetic engineering
    • 5.1.1.2. Technological development to permit the quantitative visualization of gene expression in real time
    • 5.1.1.3. Growing investment in research and government support
  • 5.1.2. Restraints
    • 5.1.2.1. Necessity for molecular oxygen to generate luminescence
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing uses in beverage industry to check microbial contamination
    • 5.1.3.2. Strategic collaboration between players
  • 5.1.4. Challenges
    • 5.1.4.1. Associated technical issues
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Luciferase Assays Market, by Method

• 6.1. Introduction
• 6.2. Dual Reporter Assay
• 6.3. Flash Assay
• 6.4. Glow Assay
• 6.5. Single Reporter Assay

7. Luciferase Assays Market, by Application

• 7.1. Introduction
• 7.2. Gene Expression
• 7.3. Metabolic Activity
• 7.4. Protein-Protein Interaction
• 7.5. Post-Translational Modification

8. Americas Luciferase Assays Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Luciferase Assays Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Luciferase Assays Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AAT Bioquest, Inc.
• 2. Abcam PLC
• 3. Active Motif, Inc.
• 4. Biotium
• 5. GeneCopoeia, Inc.
• 6. Gold Biotechnology
• 7. Invivogen
• 8. Lonza Group AG
• 9. Merck KGaA
• 10. Molecular Devices, LLC
• 11. Novus Biologicals
• 12. OriGene Technologies, Inc.
• 13. OZ Biosciences
• 14. Perkin Elmer, Inc.
• 15. Promega Corporation
• 16. PromoCell GmbH
• 17. SwitchGear Genomics, Inc.
• 18. Takara Bio Inc.
• 19. Thermo Fisher Scientific, Inc.